The Federal Circuit affirmed the PTAB’s ruling that Medtronic failed to prove Teleflex’s guide extension catheter patents unpatentable, finding that the claimed invention was conceived and reduced to practice before the critical date of the asserted prior art.
The Federal Circuit dismissed Allgenesis’s appeal from an adverse IPR decision for lack of Article III standing, holding that vague future product plans and non-appealable priority rulings do not constitute a concrete injury sufficient to invoke federal court jurisdiction.
The Federal Circuit vacated an infringement judgment in an ANDA case involving pulmonary hypertension drug patents, holding that the district court erred by construing ‘a pH of 13’ based solely on intrinsic evidence when the parties submitted competing extrinsic evidence—including textbo
The Federal Circuit upheld attorneys’ fee awards against PersonalWeb, affirming that the Kessler doctrine barred it from suing Amazon’s customers after PersonalWeb had stipulated to dismissal with prejudice of its earlier case against Amazon itself.
In a split decision, the Federal Circuit affirmed PTAB’s patentability finding for DivX’s media streaming patents, holding that Netflix forfeited its arguments by failing to present them with sufficient clarity in the IPR petition.
The Federal Circuit vacated a multi-million dollar patent damages award against Chilisin Electronics, holding that the district court abused its discretion by admitting a damages expert opinion that failed to differentiate between infringing and non-infringing products in the royalty base calculatio
The Federal Circuit partially affirmed and partially vacated PTAB’s obviousness rulings on Corephotonics dual-aperture camera patents, holding that one prior art reference was analogous on substantial evidence but remanding for the Board to explain whether a second reference meets the analogou
The Federal Circuit vacated an invalidity judgment against Finjan’s cybersecurity patents that had been based on collateral estoppel from a since-vacated case, while affirming non-infringement on claim construction grounds and excluding Finjan’s damages expert for inadequate apportionmen
The Federal Circuit held that the PTAB erred in categorically excluding expert testimony on the structure of computer-implemented means-plus-function claim limitations when the specification identifies named software protocols, clarifying a two-track framework for evaluating such claims.
The Federal Circuit affirmed PTAB’s obviousness finding for radiosurgery patents, clarifying that a reasonable expectation of success does not require an explicit separate finding and may be implicit in a well-supported motivation-to-combine analysis.